Press Releases

Pharmaceutical Glass Packaging Market to Expand at a CAGR of 10.8 % from 2021 to 2030

Share This Article

Pharmaceutical Glass Packaging Market size was valued at USD 6.79 Billion in 2020 and is projected to reach USD 9.40 Billion by 2030, growing at a CAGR of 10.8% from 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38629

Growth Factors

 The demand for pharmaceutical glass packaging is projected to be driven by the growth of the pharmaceutical industry in emerging economies, especially in the Asia Pacific region.

The cost sensitivity in the healthcare sector and the growing significance of biotech drugs have resulted in the establishment of stringent regulations related to drug delivery products. Many pharmaceutical drugs manufacturing companies are focused on increasing the shelf life of a drug and are therefore making investments in the research and development of glass vials. The newly developed products are expected to aid the growth of glass vials due to the expansive number of applications. The generic drug type segment is expected to witness the fastest growth in terms of revenue as well as volume over the forecast period. This is due to the significant increase in the volume of generics in the country, which is estimated to face a rapid change in the market dynamics primarily due to the increased competitive intensity and customer consolidation.

Report Coverage

Report Scope Details
Market Size USD 9.40 billion by 2030
Growth Rate CAGR of 10.8% From 2021 to 2030
Base Year 2021
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Product, Drug type
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Corning Incorporated; Nipro Corporation; SGD S.A.; Stölzle-Oberglas GmbH; Bormioli Pharma S.r.l; West Pharmaceutical Services, Inc.; Schott AG; Gerresheimer AG; Shandong Medicinal Glass Co., Ltd.; Beatson Clark; Ardagh Group S.A.; Arab Pharmaceutical Glass Co.; Piramal Enterprises Ltd.; Şişecam Group; Owens-Illinois, Inc.

Report Highlights

Bottles held the highest share of 36.1% in terms of revenue in 2020. The market has been segmented on the basis of product as ampoules, bottles, vials, and syringes and cartridges. Vials are expected to expand at the second-fastest revenue-based CAGR after ampoules from 2021 to 2030 owing to their high analytical performance and great sustainability.

Glass bottles used for pharmaceutical packaging are categorized into two types depending on the size, namely small bottles and large bottles. The large size glass bottles are used for the packaging of reagents as well as transfusion and infusion bottles.

Ampoules accounted for the highest volume share of 76.7% in 2020 owing to their better analytical performance and suitability. A large number of ampoules are produced in compliance with the DIN ISO EN 9187-1/2 standard in sealed designs, funnel-type, and straight-stem.

The generic drug type segment led the market and dominated for 72.2% share of the global revenue in 2020. The global market for generic drugs has witnessed growth in the past several years due to the increasing cases of chronic diseases, the aging population, and the rise in the expiration of drug patents.

The generic drug type segment in North America is expected to witness higher growth than the branded drug type segment, both in terms of volume and revenue, as it is affordable, whereas the patent expirations are further going to lead the branded segment to expand at a moderate growth rate.

In terms of revenue, six biologic drugs accounted for the top ten in 2016. The pharmaceutical industry is expected to largely benefit from biologics as they cater to therapeutic aspects that are underserved. The biosimilar competition for biologics has remained low resulting in the moderate growth of the segment, thereby slowing the growth of the segment in the market.

North America dominated the market and dominated for a 39.5% share of the global revenue in 2020. The developing markets are expected to witness a surge in spending on the pharmaceutical industry over the upcoming years.

The European region held for an 19.1% share of the overall volume in 2020. The research-based pharmaceutical industry is a key asset of the European economy. The pharmaceutical glass packaging industry is on the rise owing to the growth in medical progress by means of research, development, and introduction of new medicines aimed at improving the health and quality of life of patients in the region.

Key Players

  • Corning Incorporated
  • Nipro Corporation
  • SGD S.A.
  • Stölzle-Oberglas GmbH
  • Bormioli Pharma S.r.l
  • West Pharmaceutical Services, Inc.
  • Schott AG
  • Gerresheimer AG
  • Shandong Medicinal Glass Co., Ltd.
  • Beatson Clark
  • Ardagh Group S.A.
  • Arab Pharmaceutical Glass Co.
  • Piramal Enterprises Ltd.
  • Şişecam Group
  • Owens-Illinois, Inc.

Market Segmentation

  • Product
    • Vials
      • Small vials
      • Large vials
    • Bottles
      • Small bottles
      • Large bottles
    • Cartridges & Syringes
    • Ampoules
  • Drug Type
    • Generic
    • Branded
    • Biologic
  • Regional
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Central & South America (CSA)
      •  Brazil
    • Middle East & Africa (MEA)
      • Saudi Arabia

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38629

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Pharmaceutical Glass Packaging Market, By Product

7.1.  Pharmaceutical Glass Packaging Market, by Product, 2021-2030

7.1.1.    Vials

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Bottles

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Cartridges & Syringes

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Ampoules

7.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Pharmaceutical Glass Packaging Market, By Drug Type

8.1.  Pharmaceutical Glass Packaging Market, by Drug Type, 2021-2030

8.1.1.    Generic

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Branded

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    Biologic

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Pharmaceutical Glass Packaging Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Product (2017-2030)

9.1.2.    Market Revenue and Forecast, by Drug Type (2017-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Product (2017-2030)

9.1.3.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Product (2017-2030)

9.1.4.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Product (2017-2030)

9.2.2.    Market Revenue and Forecast, by Drug Type (2017-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Product (2017-2030)

9.2.3.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Product (2017-2030)

9.2.4.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Product (2017-2030)

9.2.5.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Product (2017-2030)

9.2.6.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Product (2017-2030)

9.3.2.    Market Revenue and Forecast, by Drug Type (2017-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Product (2017-2030)

9.3.3.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Product (2017-2030)

9.3.4.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Product (2017-2030)

9.3.5.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Product (2017-2030)

9.3.6.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Product (2017-2030)

9.4.2.    Market Revenue and Forecast, by Drug Type (2017-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Product (2017-2030)

9.4.3.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Product (2017-2030)

9.4.4.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Product (2017-2030)

9.4.5.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Product (2017-2030)

9.4.6.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Product (2017-2030)

9.5.2.    Market Revenue and Forecast, by Drug Type (2017-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Product (2017-2030)

9.5.3.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Product (2017-2030)

9.5.4.2.        Market Revenue and Forecast, by Drug Type (2017-2030)

Chapter 10.  Company Profiles

10.1.              Corning Incorporated

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Nipro Corporation

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              SGD S.A.

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Stölzle-Oberglas GmbH

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Bormioli Pharma S.r.l

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              West Pharmaceutical Services, Inc.

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Schott AG

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Gerresheimer AG

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Shandong Medicinal Glass Co., Ltd.

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Beatson Clark

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

12.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38629

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Related Articles

Back to top button